Who Paid My Doc
Eversense
Device Endocrinology
General payments
$780,365
Research payments
$33,210,008
Through program year 2025, $780,365 in general payments and $33,210,008 in research payments were reported against Eversense (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $73,556 | 199 |
| 2025 | Research | $1,685,383 | 686 |
| 2024 | General | $65,384 | 141 |
| 2024 | Research | $2,836,718 | 231 |
| 2023 | General | $107,181 | 69 |
| 2023 | Research | $10,938,309 | 383 |
| 2022 | General | $29,634 | 60 |
| 2022 | Research | $7,712,152 | 256 |
| 2021 | General | $19,280 | 44 |
| 2021 | Research | $1,414,665 | 96 |
| 2020 | General | $207,441 | 494 |
| 2020 | Research | $2,239,222 | 112 |
| 2019 | General | $277,889 | 1,399 |
| 2019 | Research | $6,383,558 | 131 |
Breakdown
The top 5 of 80 recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,406 general · 1,895 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.